On this page:

Oral Abstract Presenters

We are excited to have you join us as an abstract presenter during The Liver Meeting Digital Experience™ (TLMdX). This year, AASLD will work with Freeman to offer a bold, captivating digital event using the platform OnlineEvent®Pro. All presentations will be recorded prior to the event to allow you the unique opportunity to engage with the audience while your presentation is streaming using the platform's interactive text chat and Q&A features.

Register

Key Details and Deadlines

As you prepare to present at TLMdX™, please remember to:

  • Register for TLMdX here.
  • Check out the Speaker Center to understand the format and time slot for your presentation.
  • Download the official AASLD TLMdX PowerPoint Presentation Template to develop your presentation.
  • Review AASLD's Faculty Agreement and Presentation Guidelines presented in the formal invitations to ensure your presentation is in compliance.
  • Confirm that the content you are preparing for presentation meets AASLD's Disclosure Policy and the ACCME Standards for Commercial Support.
  • Upload your presentation to OnlineEvent®Pro no later than October 15, 2020. To ensure all presentations are successfully transitioned into the digital format for the meeting, all presenters are required to upload their recorded presentations as an MP4 file by October 15.
  • Presentations must remain within the allotted 10 minute presentation time; failure to meet this requirement may prevent your presentation from being included in the meeting.
  • Plan accordingly! There are no exceptions for late submissions received or requests for revisions after the October 15, 2020 deadline.
  • Presenting authors are invited to participate in a live moderated Q&A at the end of the presentation session. More details will be available closer to the meeting.

If you cannot present during TLMdX, please inform AASLD staff at your earliest convenience.

Speaker Center

The Speaker Center is your one-stop-shop to view your confirmed faculty engagements and session information, and to plan your meeting schedule.

Visit the Speaker Center

Preparing Content and Deliverables

To help you develop your presentation, please find a list of required slide content required below.

Download the Virtual Presenter Toolkit for tips and tricks to ensure your PowerPoint and recording are the best they can be.

Required Slide Content:

  • Introduction Slide: Provide a brief background on yourself or your experience/expertise in the field
  • Disclosure Slides: Include a disclosure slide at the beginning of your presentation(s).
  • Key Take-Away Slide: Include at least one key takeaway slide in your presentation(s). The goal for this slide is to briefly summarize your key findings in a bullet point format; provide recommendations or actions to reinstate your message. Consider what “take-aways / key points” you want the attendees to remember from your presentation.
  • Copyright: If your slides contain images, illustrations, figures, tables, or text that has been published elsewhere or came from another source, you are responsible for requesting and securing permission from the copyright holder to include the material(s) in your presentation slides and authorize AASLD to record the presentation.
  • HIPAA: You are responsible for removing all patient-identifying information from your presentation. If your slides contain images or information about patients or other individuals, you are responsible for obtaining appropriate patient consent (including HIPAA authorization, if applicable) to include the material in your slides and authorize AASLD to record the presentation. For more information, visit Health Information Privacy.

Embargo Policy

All attendees, members of the media, companies, institutions, organizations, universities, investment advisors, and all other individuals, are required to abide by AASLD’s Abstract Embargo Policy governing The Liver Meeting®. An embargo means that information from any abstract or presentation is confidential and may not be announced, publicized, or distributed before the embargo date and time except as permitted by this policy.

Accepted abstracts are made available to the public on the AASLD website in early October and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts will be available on the AASLD website and the online planner of The Liver Meeting Digital Experience™ November 13 at 10:00 am ET and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website.

Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00 am local time of the meeting location on the first day of the meeting.

The purpose of the embargo policy is to protect the scientific integrity of the abstract submissions presented at TLMdX. Violation of the embargo policy by release of information contained in any abstract prior to its embargoed date and time may result in the individual, as well as the employer/affiliated company, institution, organization, etc., being removed from The Liver Meeting®, with a potential two-year ban on returning. Authors are responsible for notifying financial and other sponsors about this policy.

View the Embargo Policy for more information.